TITLE

Life Sciences Briefs

PUB. DATE
February 1999
SOURCE
Chemical Market Reporter;02/01/99, Vol. 255 Issue 5, p18
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Presents several articles pertaining to life sciences in the United States. Move of Amgen Inc. in subscribing to the high throughput screening technology access program of Caliper Technologies; Expansion of the scope of several agreements that BASF AG has formed with Lynx Therapeutics Inc.; Termination of the discussions of Cox Technologies Inc. to acquire ProLogic Management Systems Inc.; Acquisition of Integra LifeSciences Corporation by HealthPoint Ltd.
ACCESSION #
1536474

 

Related Articles

  • BASF invests $66 million in venture with U.S. firm. Rotman, David // Chemical Week;10/30/1996, Vol. 158 Issue 41, p18 

    Reports on BASF's agreement to form a joint venture with biotechnology firm Lynx Therapeutics of Hayward, California. BASF's investment in the new company to be called BASF-Lynx Bioscience; Lynx's development of gene sequencing technology that could simultaneously analyze the activity of all the...

  • Life Science Briefs.  // Chemical Market Reporter;09/04/2000, Vol. 258 Issue 10, p14 

    Presents news briefs on the life sciences industry as of September 4, 2000. Clinical trial of the drug Seroquel by Astrazeneca; Reported life science sales of Aventis for the first half of 2000; Revenue generated by Caliper Technologies Corp. through its common stocks.

  • BASF May Favor Life Sciences At the Expense of Pharmaceuticals. Milmo, Sean // Chemical Market Reporter;11/15/99, Vol. 256 Issue 20, p8 

    Reports that BASF hinted that it may dispose of part or all of its pharmaceutical business to strengthen its position in another life science sector. Reason for the difficulty of BASF in marketing its obesity drug Meridia/Reductil; Reason behind the increase of the company's pharmaceutical...

  • Europe in Brief. Milmo, Sean // Chemical Market Reporter;02/07/2000, Vol. 257 Issue 6, p6 

    Presents updates on several chemical companies in Europe as of February 2000. Manufacturing agreement reached by Avecia LifeScience Molecules company and Ribozyme Pharmaceuticals Inc.; Dimethyl acetamide capacity of BASF company.

  • Crop Protection.  // American Vegetable Grower;Nov2007, Vol. 55 Issue 11, p6 

    This section presents news briefs on crop protection. Arysta LifeScience has received U.S. Environmental Protection Agency (EPA) registration for one year for Midas, a broad-spectrum soil fumigant. BASF has received federal registration for Regent, an insecticide for controlling wireworms in...

  • BASF Collaborates with Solvias to Develop Chiral Intermediates. Scott, Alex // Chemical Week;10/13/2004, Vol. 166 Issue 33, p31 

    Reports on the collaboration agreement entered into by BASF with custom research company Solvias to provide chiral ligands for the manufacture of chirally pure intermediates for pharmaceuticals and other life science products. Details of the agreement; Role of BASF in the final version of...

  • BASF builds PTHF plant in Korea...  // Chemical Week;8/2/95, Vol. 157 Issue 4, p22 

    Reports on BASF AG's construction of a polytetrahydrofuran plant in Ulsan, South Korea.

  • BASF to raise neopentyl glycol capacity.  // Chemical Week;9/13/1995, Vol. 157 Issue 9, p26 

    Reports that BASF has announced plans to build a neopentyl glycol (NPG) plant at its German site. Total NPG capacity following plant completion; Other BASF sites producing NPG.

  • BASF propionic acid.  // Chemical Week;9/13/1995, Vol. 157 Issue 9, p38 

    Reports that BASF has announced an increase in its propionic acid capacity at Ludwigshafen, Germany in response to increasing demand for captive and external use in North American and Asia.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics